Contents
Where does the FDA receive drug adverse event data?
The openFDA drug adverse event API returns data that has been collected from the FDA Adverse Event Reporting System (FAERS), a database that contains information on adverse event and medication error reports submitted to FDA.
Why are there so many drug adverse events?
Concomitant drugs are those which are not suspected of causing one or more of the reactions. Many drug products appear frequently in adverse event reports simply because they are commonly taken by many people in the population, not because they are responsible for more adverse events.
Which is the standard for an adverse event report?
Adverse event reports use the ICH E2b/M2 version 2.1 standard. This highly simplified schematic illustrates the general nature of an adverse event report. A report may list several drug products, as well as several patient reactions. No individual drug is connected to any individual reaction.
What is an adverse drug reaction ( ADR )?
What is an adverse drug reaction (ADR)? An . adverse drug reaction. is a “response to a drug which is noxious and unintended and which occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of disease or for the modification of physiologic function.” Note that there is a causal link between a drug and an adverse drug reaction.
What causes increase in number of adverse events?
Increases in the total number of adverse events is likely caused by improved reporting. FAERS data does have limitations. There is no certainty that the reported event (adverse event or medication error) was actually due to the product.
When is a drug marked as a suspect?
Any number of the drugs may be marked as suspect if thought to be responsible for one or more of the reactions, but that information is not validated. Concomitant drugs are those which are not suspected of causing one or more of the reactions.
What does FAERS mean for a biologic drug?
For example, while FAERS contains reports on a particular drug or biologic, this does not mean that the drug or biologic caused the adverse event. Importantly, the FAERS data by themselves are not an indicator of the safety profile of the drug or biologic.
Where can I find an animal Adverse EVENT report?
In the spirit of openness and transparency, the FDA’s Center for Veterinary Medicine now makes adverse event reports (AERs) related to animal drugs and devices used in animals available on openFDA.gov, a platform electronically accessible to the general public.
When was the first adverse event reported to CVM?
The initial dataset on openFDA.gov includes AER data from January 1, 1987 to September 30, 2018. CVM updates the information quarterly to ensure that the public has the most current information available about adverse events reported to CVM in relation to drugs and devices used in animals.
When did the FDA start the OpenFDA initiative?
Now, openFDA, an FDA Office of Health Informatics initiative launched in June 2014, is making it easier for researchers, scientists, web developers, and other FDA regulatory stakeholders to access and use those datasets in an open standard format.
Where do device adverse event reports come from?
Device adverse event reports vary significantly, depending on who initially reported the event, what kind of event was reported, and whether there were follow-up reports. Some reports come directly from user facilities (like hospitals) or device importers (distributors), while others come directly from manufacturers.
How is OpenFDA used in the scientific community?
Members of the scientific community can use openFDA to have their applications automatically query the data through application program interfaces (APIs). OpenFDA increases the efficiency and speed of accessing datasets by using cutting-edge, open-source code modules in a cloud-based environment.
How does OpenFDA improve access to datasets?
OpenFDA increases the efficiency and speed of accessing datasets by using cutting-edge, open-source code modules in a cloud-based environment. Nimble and user-centered product development methodologies are being used to expand and improve the platform and ensure user friendliness of its functions.